Invasive lobular carcinoma
Invasive lobular carcinoma | |
---|---|
Lobules of the mammary glands. | |
Specialty | Oncology |
Invasive lobular carcinoma (ILC) is
Types
Classic lobular | Pleomorphic lobular | |
---|---|---|
Grades | Low or high (II/III) | High (III) |
AJCC stage | I | II |
Lymph node status | Negative | Positive |
ER/PR status | Positive | Positive |
Surgery type | Lumpectomy | Mastectomy |
The histologic patterns include:[6][7][8]
Type | Prevalence | Description | Image |
---|---|---|---|
Classical | 40% | Round or ovoid cells with little cytoplasm in a single-file infiltrating pattern, sometimes concentrically giving a targetoid pattern | |
Mixed | 40% | No dominant pattern | |
Solid | 10% | Sheets of classical-appearing cells with little intervening stroma
| |
Alveolar | 5% | Aggregates of classical-appearing cells | |
Tubulolobular | 5% | Cells form microtubules in >90% of tumor (smaller than in tubular carcinoma) | |
Pleomorphic | Classical-appearing but with pleomorphic cells. It may include signet-ring cells, or plasmacytoid cells (pictured) which have abundant cytoplasm and eccentric nuclei. |
-
Histopathology of invasive lobular carcinoma (ILC), next to lobular carcinoma in situ (LCIS)
-
Invasive lobular carcinoma demonstrating a predominantly lobular growth pattern
-
Lobular breast cancer. Single file cells and cell nests.
-
ILC may be subtle on low magnification (left). Higher magnification (right) shows invasive growth pattern and vesicular nuclei with prominent nucleoli.
Prognosis
Overall, the five-year survival rate of invasive lobular carcinoma was approximately 85% in 2003.[9]
Diagnosis
On mammography, ILC shows spiculated mass with ill-defined margins that has similar or lower density than surrounding breast tissues. This happens only at 44–65% of the time. Architectural distortion on surrounding breast tissues is only seen in 10–34% of the cases. It can be reported as benign in 8–16% of the mammography cases.[10]
Ultrasound has 68–98% sensitivity of detecting ILC. ILC shows irregular or angular mass with hypoechoic or heterogenous internal echoes, ill-defined or spiculated margins, and posterior acoustic shadowin.[10]
Loss of
Treatment
Treatment includes surgery and adjuvant therapy.
References
- ^ "Breast Cancer Treatment (PDQ®)". NCI. 23 May 2014. Archived from the original on 5 July 2014. Retrieved 29 June 2014.
- PMID 14731438.
- PMID 19280264.
- PMID 31880271.
- PMID 29131529.
- PMID 10816631.
- S2CID 24935891.
- ^ Fletcher's diagnostic histopathology of tumors. 3rd Ed. p. 931-932.
- PMID 15084238.
- ^ PMID 19168843.
- PMID 19850991.